DermTech, Inc. (DMTK) Reports Q4 Loss, Misses Revenue Estimates

DermTech, Inc. (DMTK) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.93 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -3.70%. A quarter ago, it was expected that this company would post a loss of $0.68 per share when it actually produced a loss of $0.57, delivering a surprise of 16.18%.Over the last four quarters, the company has surpassed ...